Clinical Trial Update: GUIDOR® Growth Factor Enhanced Bone Graft Substitute for the Treatment of Periodontal Defects 6-months Post-Surgery [NA]

View source ↗

Summary

Clinical trial update on GUIDOR growth factor enhanced bone graft substitute for periodontal defects; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Bone Loss
• Periodontal Diseases

Drugs mentioned

• GUIDOR Growth Factor Enhanced Bone Graft Substitute

Snippet

Sponsor: Sunstar Americas | Conditions: Alveolar Bone Loss, Periodontal Diseases | NA | Status: COMPLETED | Results posted: 2020-08-21